Merck's experimental two-drug combination met the main goal of significantly suppressing replication of the HIV-1 virus in ...

Ending HIV Together: Michigan’s Equitable Plan aims to reduce new HIV infections by 90% by 2030. Aligned with the U.S.

U.S. drugmaker Merck said on Thursday its experimental combination treatment for some adults with HIV-1 infection met the ...

The symptoms of SJS include: Your treatment plan for an HIV rash will depend on the cause of the rash. If you are HIV positive and experience a rash that isn’t relieved by over-the-counter drugs ...

As we mark the holidays, here are a few of the many heroes who are working to build a stronger global health future by ...

This issue highlights a broader concern regarding medication coverage and affordable health care. It underscores the critical ...

The human immune deficiency virus (HIV) first entered public consciousness in the early 1980s, after cases of unfamiliar and deadly illnesses began to overwhelm medical centers across North America.

The population most affected by HIV has changed in recent years, and public health messaging may not be reaching the ...

Antiretrovirals are necessary to delay disease progression but the undesirable side effects often affect the patient’s ...

As the new cases and related deaths fall in sub-Saharan Africa, the virus is rearing its head elsewhere. What's the cause?

RAHIM YAR KHAN: Another HIV positive patient of the surgical ward of the Shaikh Zayed Medical College Hospital (SZMCH) was ...

What does the HIV response look like beyond the 2030 targets to end AIDS? For the past year, UNAIDS has been working with ...